U.S. CBP and FDA Seize 165,000 Illicit E-Cigarette Products; Total Value Exceeds $1.47 Million

Sep.30.2025
U.S. CBP and FDA Seize 165,000 Illicit E-Cigarette Products; Total Value Exceeds $1.47 Million
U.S. Customs and Border Protection (CBP) seized approximately 165,000 illicit vaping products—including 90,000 e-cigarette devices and 75,000 refill cartridges—valued at over $1.47 million (MSRP). Following a joint assessment with the U.S. Food and Drug Administration (FDA), the products were deemed “adulterated and misbranded” for lacking required premarket authorization and were seized in accordance with the Federal Food, Drug, and Cosmetic Act (FD&C Act). The shipments, which featured multipl

Key Points

 

  • Seizure scale: 165,000 units in total—90,000 ENDS devices and 75,000 refill cartridges—with an MSRP exceeding $1.47 million.

 

  • Nature of violations: Lack of FDA premarket authorization (PMTA); products deemed “adulterated and misbranded” under the FD&C Act.

 

  • Flavors involved: Blue Razz, Iced Lush, Blue Lightning, Gum Mint, Turkish Tobacco, Classic Tobacco, among others.

 

  • Related enforcement: Intelligence support from CBP’s Chicago Field Office aided the interdiction; earlier Chicago operations seized about 4.7 million units (valued at ~$86.5 million), and last week the DOJ and FDA reported over 2.1 million illicit vaping products seized nationwide.

 


 

2Firsts, September 29, 2025 — U.S. Customs and Border Protection (CBP) announced that officers in the Minneapolis–St. Paul area recently inspected multiple pallets and discovered roughly 165,000 e-cigarette devices and refill cartridges—comprising 90,000 devices and 75,000 cartridges.

 

After a joint evaluation by CBP and the U.S. Food and Drug Administration (FDA), the products were determined to lack the FDA’s required premarket authorization and therefore cannot be legally sold in the United States. They were further classified as “adulterated” and “misbranded” under the FD&C Act and seized accordingly. The Manufacturer’s Suggested Retail Price (MSRP) for the shipments is estimated to exceed $1.47 million. All consignments reportedly originated in China and were destined for a wholesaler in California.

 

U.S. CBP and FDA Seize 165,000 Illicit E-Cigarette Products; Total Value Exceeds $1.47 Million
Image source: cbp.gov

 

CBP noted that the interdiction benefited from intelligence sharing with the Chicago Field Office. The seized items included a variety of flavors such as Blue Razz, Iced Lush, Blue Lightning, Gum Mint, Turkish Tobacco, and Classic Tobacco. CBP said it will continue working with the FDA and other partners to identify and seize unsafe and illicit goods, and reminded importers and e-commerce buyers to ensure their purchases and importations comply with federal and state regulations.

 

U.S. CBP and FDA Seize 165,000 Illicit E-Cigarette Products; Total Value Exceeds $1.47 Million
Image source: cbp.gov

 

Federal agencies have recently intensified enforcement nationally. Earlier this month, CBP, the U.S. Department of Health and Human Services (HHS), and the FDA conducted a joint operation in Chicago that seized approximately 4.7 million unauthorized e-cigarettes valued at about $86.5 million. Last week, the U.S. Department of Justice (DOJ) and FDA also announced coordinated actions across seven states that resulted in the seizure of more than 2.1 million illicit vaping products. (Read more: Largest E-Cigarette Seizure in U.S. History: Over 600,000 Products Confiscated from Midwest Goods Warehouse; Company Denies Violations, Calls FDA “Unfair”)

 

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

UK Directors Banned After 352,688 Vapes Imported From China Were Misdeclared as Medical Nebulizers in £15 Million Tax Case
UK Directors Banned After 352,688 Vapes Imported From China Were Misdeclared as Medical Nebulizers in £15 Million Tax Case
The UK Insolvency Service said YSK Enterprises imported large quantities of vapes from China in 2023, with a shipment addressed to the company declared as medical nebulizers before Border Force found 352,688 vaping products. HMRC calculated nearly £15 million ($20.3 million) in unpaid VAT and customs duty, alongside about £437,000 in corporation tax. Two directors were disqualified for nine years. The case predates the UK's Vaping Products Duty, which will introduce vape-specific excise and duty-stamp requirements from October 2026.
Regulations
Sep.11
Special Report|Virginia Vape Directory Shows Contrast Between Vuse and JUUL Pod Systems and CrossBar 20K, Loon Flavored Disposables
Special Report|Virginia Vape Directory Shows Contrast Between Vuse and JUUL Pod Systems and CrossBar 20K, Loon Flavored Disposables
A 2Firsts analysis of Virginia's liquid nicotine and vapor product certification directory identified 213 product records from 15 manufacturers. Companies associated with BAT, Altria, Imperial Brands, JTI and JUUL account for 127 entries. The directory also includes independent brands CrossBar 20K, Loon and Breeze. CrossBar advertises a 13mL disposable capable of up to 20,000 puffs, while Loon has 16 disposable entries featuring fruit, cooling and beverage-related flavors. Of all records, 120 are labeled as under FDA PMTA review. Virginia introduced revised penalties on October 1, 2026, including a minimum first-violation civil penalty of $5,000 per unlisted product, alongside new retail tobacco permitting requirements.
Regulations
Oct.30
How Many Nicotine Pouch Factories Does Europe Need? 2Firsts Interviews AIRSCREAM on the OEM Market
How Many Nicotine Pouch Factories Does Europe Need? 2Firsts Interviews AIRSCREAM on the OEM Market
At InterTabac 2026, nicotine pouch growth was visible not only in brands but across equipment, raw materials and OEM manufacturing. 2Firsts interviewed AIRSCREAM commercial head Steve Moore on how many pouch factories Europe may ultimately need and where manufacturers can differentiate, from formulation and flavour to pouch materials, production consistency and customer service. The category continues to expand, but questions remain over future capacity, consolidation and the long-term structure of the supply chain.
Sep.18
Product | Four CrossBar 20K 13mL High-Puff Vapes Listed on Pennsylvania's ENDS Directory, Rated for Up to 20,000 Puffs
Product | Four CrossBar 20K 13mL High-Puff Vapes Listed on Pennsylvania's ENDS Directory, Rated for Up to 20,000 Puffs
Four CrossBar 20K disposable e-cigarettes appeared on Pennsylvania's 163-entry ENDS directory ahead of enforcement beginning October 19, 2026. The devices feature 13mL e-liquid reservoirs, 50mg/mL nicotine, 2,000mAh batteries and 0.9Ω mesh coils, with advertised puff counts of up to 20,000. CrossBar was the only modern high-puff disposable series among the directory's 15 disposable entries. Its packaging emphasizes New York design and Japanese-origin flavoring, while historical CrossBar records identify a registered U.S. tobacco manufacturing-related establishment. The link between the newer 13mL devices and earlier 1.3mL PMTA filings remains unconfirmed.
product
Oct.26
India Steps Up Nicotine Pouch Enforcement as ZYN, White Fox Circulate and Drug Panel Urges Halt to New Nicotine Formulations
India Steps Up Nicotine Pouch Enforcement as ZYN, White Fox Circulate and Drug Panel Urges Halt to New Nicotine Formulations
India's Ministry of Health and Family Welfare has directed states to step up enforcement against nicotine pouch sales, citing increased availability through online and offline channels and concern about nicotine exposure among children. Reuters reported that international brands including ZYN and White Fox are being sold in India. A study led by ICMR-NICPR found pouches in seven of 10 surveyed locations and identified 68 brands and 445 flavors online. Separately, India's Drugs Technical Advisory Board recommended in August that no new nicotine formulation be approved.
Regulations
Sep.28 by 2Firsts Perspectives
As JUUL2 Wins FDA Authorization, Harm Reduction Journal Highlights the Role of Real-World Evidence in Nicotine Product Regulation
As JUUL2 Wins FDA Authorization, Harm Reduction Journal Highlights the Role of Real-World Evidence in Nicotine Product Regulation
A commentary published in the international open-access, peer-reviewed Harm Reduction Journal argues that randomized controlled trials remain central to evaluating smoking cessation efficacy but cannot alone capture real-world uptake, complete switching, longer-term use and population impact of non-combustible nicotine products such as e-cigarettes, heated tobacco and nicotine pouches. The authors frame impact as “reach × efficacy” and call for real-world evidence to complement RCTs. Three days after publication, the FDA authorized three JUUL2 products and highlighted complete switching among adult smokers in explaining its decision, providing a timely regulatory backdrop to the debate.
Sep.08